OA03.04 Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation
Adrian G. Sacher, M.R. Patel, W.H. Miller, J. Desai, E. Garralda, Samantha E. Bowyer, T.W. Kim, M. De Miguel, A. Falcon, M.G. Krebs, James Lee, Mingwen Cheng, S.-W. Han, E. Shacham-Shmueli, M. Forster, G. Jerusalem, E. Massarelli, Luis Paz-Ares Rodríguez, H. Prenen, I. Walpole, K. Arbour, Yoonha Choi, N.V. Dharia, M. Lin, S. Mandlekar, S. Royer Joo, Zhe Shi, J. Schutzman, P. LoRusso
Topics & Concepts
MedicineKRASOncologyMutationInternal medicineLung cancerCancernon-small cell lung cancer (NSCLC)Cancer researchGeneticsColorectal cancerGeneA549 cellBiologyLung Cancer Treatments and MutationsCancer therapeutics and mechanismsLung Cancer Research Studies